Salk Institute Creates Comprehensive Epigenetic Atlas of Aging Mouse Brain to Combat Neurodegenerative Diseases

Summary

Researchers at the Salk Institute have developed the most comprehensive single-cell epigenetic atlas of the aging mouse brain to date, mapping DNA methylation, genome structure, and gene activity changes across eight brain regions and 36 distinct cell types. The atlas profiles over 200,000 single cells and nearly 900,000 cells using spatial transcriptomics, revealing clear epigenetic differences associated with aging and enabling the development of deep-learning models that predict age-related gene expression changes. Published in Cell on March 11, 2026, the atlas is now publicly available on Amazon Web Services and the Gene Expression Omnibus, serving as a critical reference framework for understanding how aging reshapes the brain at the molecular level. This resource is expected to accelerate research into the mechanisms underlying neurodegenerative diseases like Alzheimer's, Parkinson's, and ALS, which affect over 57 million people globally and are projected to double in incidence every 20 years.

• The publicly available resource on AWS and GEO serves as a critical reference framework that will accelerate research into mechanisms connecting aging to Alzheimer's, Parkinson's, and ALS

Editorial Opinion

This atlas represents a significant step forward in understanding the molecular mechanisms of brain aging, though it's important to note the findings come from mouse models and will require careful translation to human systems. The public availability of this comprehensive dataset democratizes access to critical neuroscience research and should accelerate collaborative efforts to develop therapeutic interventions. However, the complexity of converting epigenetic insights into clinical treatments for neurodegenerative diseases remains substantial, and researchers will need to carefully validate these findings in human cohorts.